FDA has cleared the IMDx HSV-1/2 assay for Abbott m2000, a test that detects and differentiates herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) DNA from male and female skin lesions from anogenital or oral sites. HSV-1 and HSV-2 are the most common causes of oral and genital lesions and are spread through sexual and skin-to-skin contact. HSV-2 affects an estimated one in six Americans, with more than 80% of those carriers unaware that they have been infected. HSV-1 infection rates are even higher, with studies estimating that 65% of Americans carry the virus. While no cure exists for HSV-associated infections, antiviral medications may shorten the duration of outbreaks, decrease their frequency, and reduce the threat of transmission to sexual partners. The IMDx HSV-1/2 assay for Abbott m2000 is manufactured by IntelligentMDx and distributed by Abbott Molecular. For more information, visit Abbott Molecular and IMDx.